Scope and epidemiology of pediatric sepsis

R Scott Watson1, Joseph A Carcillo

  • 1Department of Critical Care Medicine (RSW, JAC), Center for Research on Health Care, and the Clinical Research, Investigation, and Systems Modeling in Acute Illness Laboratory, University of Pittsburgh, Pittsburgh, PA, USA.

Insights

Pediatric sepsis is a significant global health issue, causing many deaths in children annually. Fortunately, sepsis is both preventable and treatable with simple strategies, improving child survival rates.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases epidemiology
  • Global child health

Background:

  • Sepsis is a leading cause of mortality in infants and children worldwide.
  • Over 42,000 cases of severe sepsis occur annually in the U.S., with millions globally.
  • Infants, particularly low-birth-weight babies, represent a significant portion of severe sepsis cases in the U.S.

Purpose of the Study:

  • To summarize the scope and epidemiology of pediatric sepsis.
  • To highlight the global burden of pediatric sepsis.
  • To review effective prevention and treatment strategies.

Main Methods:

  • A comprehensive review of the published scientific literature.
  • Analysis of epidemiological data on pediatric sepsis incidence and outcomes.
  • Evaluation of intervention strategies in diverse healthcare settings.

Main Results:

  • Severe sepsis affects over 42,000 children yearly in the U.S. and millions globally.
  • Underlying medical conditions are present in nearly half of U.S. pediatric sepsis cases.
  • Costly healthcare burden in the U.S. ($2.3 billion in 1999) contrasted with successful, low-cost interventions in developing nations.

Conclusions:

  • Pediatric sepsis is a critical global health concern in both developed and developing countries.
  • Sepsis is a preventable and treatable condition with the potential to significantly improve child survival and quality of life.
  • Addressing pediatric sepsis requires a multidisciplinary approach and standardized definitions due to epidemiological variations.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...